<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03482284</url>
  </required_header>
  <id_info>
    <org_study_id>UVienna18</org_study_id>
    <nct_id>NCT03482284</nct_id>
  </id_info>
  <brief_title>Effect of Monosaccharides on Intestinal Barrier Function</brief_title>
  <acronym>ENDO-META</acronym>
  <official_title>Exploratory Study on the Modulation of Endotoxemia and Metabolic Parameters: Role of Macronutrients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. Ina Bergheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to determine the effect of monosaccharides on intestinal
      barrier function in healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the intervention study normal weight participants will receive defined amounts of
      monosaccharides for several days. Before and after intervention parameters of intestinal
      barrier function will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 20, 2016</start_date>
  <completion_date type="Anticipated">September 15, 2018</completion_date>
  <primary_completion_date type="Actual">September 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants receive all interventional diets.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in parameters of intestinal barrier function</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in endotoxin plasma levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in systolic and diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in markers for glucose metabolism</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in fasting glucose and fasting insulin levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood lipid levels</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in triglyceride levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Uric Acid levels</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in Uric Acid blood levels</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Dietary Habits</condition>
  <condition>Endotoxemia</condition>
  <arm_group>
    <arm_group_label>Monosaccharide 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive standardized meals with a defined amount of monosaccharide 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monosaccharide 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive standardized meals with a defined amount of monosaccharide 2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Participants receive different monosaccharides for a defined number of days.</description>
    <arm_group_label>Monosaccharide 1</arm_group_label>
    <arm_group_label>Monosaccharide 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt;25 kg/m2

          -  no kown history of metabolic disorders or fatty liver

        Exclusion Criteria:

          -  food allergies or intolerances (esp. fructose intolerance and malabsorption)

          -  renal insufficiency

          -  chronic disease of the gastrointestinal tract

          -  taking drugs affecting lipid or glucose metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Ina Bergheim</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

